Healthcare >> Analyst Interviews >> February 24, 1999
JIM KELLY is a Vice President at Credit Suisse First Boston where he
follows the major pharmaceutical companies. Previously, he was
associated with Lehman Brothers and Anderson Consulting. Mr. Kelly
received his Bachelor's degree from Lehigh University and his MBA from
Columbia University Graduate School of Business.
STEVE PLAG is an Analyst at Credit Suisse First Boston where he follows
European pharmaceuticals. Previously, he was associated with NatWest,
BZW, Robert Fleming, Salomon Brothers, and Wood MacKenzie. Mr. Plag
received his Bachelor's degree in pharmacy from Edinburgh University and
is a member of the Royal Pharmaceutical Society. Profile
TWST: Let's start with the climate for investing in pharmaceuticalstocks in 1999. To what would you attribute the decline at the beginning
of the year? Does it reflect the fact that investors are